Ephraim Starr serves as Senior Vice President, General Counsel, and Corporate Secretary at Azenta, Inc., a leading provider of life sciences solutions focused on genomics, cryogenics, and automation technologies. In this pivotal role, he oversees all legal affairs, corporate governance, compliance, and risk management for the company, ensuring alignment with regulatory standards and strategic objectives. Starr joined Azenta in 2018, bringing a wealth of experience from his prior positions in the biotechnology and healthcare sectors, where he navigated complex mergers, acquisitions, and intellectual property disputes. His leadership has been instrumental in guiding Azenta through its rebranding and expansion efforts, fostering a culture of ethical decision-making and innovation in a rapidly evolving industry. Prior to Azenta, Starr held senior legal positions at prominent firms including Thermo Fisher Scientific and PerkinElmer, where he managed global legal teams and spearheaded initiatives that enhanced operational efficiencies and mitigated litigation risks. His notable achievements include successfully leading the legal aspects of multimillion-dollar acquisitions that expanded market presence in precision medicine and laboratory services. Starr is recognized for his expertise in corporate law, with a track record of advising on SEC filings, shareholder relations, and international trade compliance. He holds a Juris Doctor from Harvard Law School and a bachelor's degree in economics from Yale University, and he is an active member of several professional organizations, including the American Bar Association's Section of Business Law. Beyond his professional accomplishments, Starr is committed to mentoring emerging legal talent and contributing to industry discussions on ethical AI applications in life sciences. At Azenta, he has championed diversity and inclusion initiatives within the legal department, promoting equitable practices that have earned the company accolades for corporate responsibility. His strategic insights continue to drive Azenta's growth, positioning the company as a frontrunner in advancing scientific discovery and patient care worldwide.